source:[1] Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score | Corporate - EQS News (https://www.eqs-news.com/news/corporate/piram ...)[2] Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion. - BioSpace (https://www.biospace.com/press-releases/viva- ...)[3] McDermott-Led Sobi To Buy US Gout Specialist For $1.5B - Law360 (https://www.law360.com/articles/2421811/mcder ...)